Guidelines
These guidelines were developed for use in
the Bristol Royal Hospital for Children and are targeted at
clinicians only. Patients, parents or other community members using
these guidelines should do so in conjunction with a health
professional and should not rely on the information in these
guidelines as professional medical advice.
These guidelines are developed by a
multidisciplinary team of practising clinicians by consensus and
based on the evidence available. However, the guidelines
do not necessarily represent the views of all clinicians at
the Children's Hospital or other participating healthcare
organisations.
The recommendations contained in these
guidelines do not indicate an exclusive course of action or
standard of care. They do not replace the need for application of
clinical judgment to each individual presentation, nor variations
based on locality and facility type.
The inclusion of links to external websites
does not constitute an endorsement of those websites nor the
information or services offered.
Guideline users are strongly recommended to
confirm that the information contained within them, especially drug
doses, is correct by way of independent sources. The authors accept
no responsibility for any inaccuracies, information perceived as
misleading, or the success or failure of any treatment regimen
detailed in these guidelines.
Clicking on the links below will open a
separate pdf download link for the guideline.
Gastroenterology- Conditions
This guideline provides an algorithm for the assessment
and management of children with chronic abdominal pain in primary
and secondary care.
This guideline is for the initial assessment and management of
children presenting with Colitis, whether they have known
Inflammatory Bowel Disease (Crohn's disease, Ulcerative Colitis) or
not.
Coeliac Disease- Management of Paediatric
Patients
Publication Date: Feb 2020; updated Dec 2022
This clinical guideline details the agreed local care pathway
for the dietetic led management of patients with coeliac
disease.
Colonic Transit Study in Children with Constipation
Publication Date: Feb 2022
This documents details the colonic transit study
protocol.
Early Onset Inflammatory Bowel Disease and Refractory Inflammatory
Bowel Disease- Immunogenetic Investigations
Publication Date: September 2021
This guideline informs the immunogenetic investigation of
children principally with early-onset IBD to facilitate timely
access to specific treatments for disease associated with inborn
errors of immunity,
This guideline is for the initial assessment and management of
children who present with upper gastro-intestinal (GI) bleeding in
BRHC and Regional Hospitals.
Paediatric
Pancreatitis
Publication Date: July 2024
This guidelien provides guidance on the management of paediatric
pancreatitis.
Gastroenterology- Medications
Azathioprine is an immuno-modulatory agent that is used in
Paediatric Gastroenterology to maintain remission in patients with
Ulcerative Colitis and Crohn's Disease.
Ferric carboxymaltose (Ferinject®) is indicated for the
treatment of iron deficiency when oral iron preparations are
ineffective or cannot be used
Ustekinumab is a human monoclonal antibody used to treat
moderate to severe Crohn's disease.
Vedolizumab Treatment for Inflammatory Bowel Disease
Patients
Published June 2018; updated July 2022
Vedolizumab is a gut-selective immunosuppressive biologic used
to treat moderate to severe Crohn's disease and ulcerative
colitis.
Hepatology
Acute Liver Failure- Regional Guideline
Published January 2024
This is a guide to General Paediatricians and Emergency
Department physicians to recognising, stabilising, initiating
management and preventing complications of acute liver failure.
Nutrition / Intestinal Failure
